StarFish Medical merges with Kangaroo Group

StarFish Medical, Canada’s leading full-service medical device development firm, announced today that it has merged with Kangaroo Group, the visionary Toronto-based medical device industrial design and productization organization.  The resulting national entity will better serve medtech companies throughout North America with easier east coast access, increased resources and experienced medical device talent spanning the design,

The top medtech stories of early 2017

The new Trump administration and Republican Congress – and all the accompanying change and uncertainty –is the major story for the medical device industry. But there are many other medtech stories worth noting from the first quarter of 2017. There was an FDA warning over Abbott’s Absorb bioresorbable stent, a continued spate of M&A deals, a

Pages: 1 2 3 4 5 6

Permira funds to buy LSNE

Private equity firm Permira announced today that it will acquire Lyophilization Services of New England (LSNE), a contract developer and manufacturer in both the pharmaceutical and medical device industries. Permira is buying the company in partnership with management. LSNE founder and CEO Matt Halvorsen will still hold a significant equity stake in the company and will

Minnesota sees major medical device plant expansions

Medical device manufacturers are spending tens of millions of dollars on Minnesota plant expansions, but another heartening sign that the major device hub around Minneapolis-St. Paul remains robust. LISI Medical Remmele—a maker of minimally invasive surgical devices, spinal implants, and drug infusion, urologic and vascular components—plans to nearly double the size of its Big Lake, Minn.

Cynosure shareholder sue to block $1B Hologic merger

Cynosure (NSDQ:CYNO) shareholders last week filed a class-action lawsuit to halt the company’s proposed $1.44 billion sale to Hologic (NSDQ:HOLX), alleging that Cynosure’s regulatory filing recommending the transaction is missing crucial information about the company’s financial projections and the process that led up to the deal. The complaint, filed in the U.S. District Court for Massachusetts, suggested that

Meetings Analytics team joins ZS

Meetings Analytics, a data analytics firm that helps companies implement and improve consolidated meetings management programs, will join ZS, the global sales and marketing firm, to expand ZS’s data and analytics capabilities Founded in 2008 by Kimberly Meyer and Peter Matthews, Meetings Analytics offers business intelligence and analytics, data and compliance management and consulting services

Wenzel Spine completes buy of OsteoMed PrimaLok assets

Spinal disorder device developer Wenzel Spine said today it completed its acquisition of OsteoMed’s PrimaLok SP interspinous fusion system and FF facet fixation system. The acquired platform includes a polyaxial interspinous process device and percutaneous facet screw system for minimally invasive surgical treatments for lumbar spinal disorders, Austin, Texas-based Wenzel Spine said. “I am pleased that

Nordson and MedPlast are divvying up Vention Medical

Nordson and MedPlast are each acquiring a piece of Vention Medical in the latest M&A deal to transform the medical device contract manufacturing landscape. Nordson (Westlake, Ohio) will pay $705 million in cash to acquire Vention’s advanced technologies division, which has locations in New Hampshire, Tennessee, Ireland, Minneapolis, Massachusetts, California, Colorado and Israel. MedPlast (Tempe,

Catalent acquires softgel manufacturer Accucaps

Catalent (NYSE:CTLT) said today that it closed its acquisition of Canada-based Accucaps and its pharmaceutical soft-gel manufacturing capabilities. The Somerset, N.J.-based company did not disclose the deal’s financial details. In November, Catalent said that it planned to fund the Accucaps buy with a $400 million debt offering. Get the full story at our sister site, Drug Delivery Business News.

S&P: Medtech outlook stable, even after downgrades

The outlook for investment-grade medical device companies remains stable even after a 3-year streak of 9 consecutive downgrades, according to a new report from S&P. The downgrade of investment-grade medical device companies was mostly caused by debt-financed mergers and acquisitions, according to S&P. Factors like changes in operating performance trends and financial policy also contributed

Dow Chemical’s silicone business play: what it means for medtech

Heather Thompson, Senior Editor Dow Chemical as of mid-2016 became 100% owner of Dow Corning’s silicones business. The move created both an opportunity and challenge because it represents a marriage of organic chemistry and inorganic chemistry. How can the two complement each other and drive innovation? And how will the deal affect the medical device

How Trelleborg is getting the most out of its acquisitions

Heather Thompson, Senior Editor As is the case with many medical device industry suppliers, Trelleborg has engaged in a spate of acquisitions to broaden its offerings and better serve the growing needs of its OEM customers. Last year, Trelleborg, Sweden–based Trelleborg announced the acquisition of Tustin, California–based Specialty Silicone Fabricators. They’ve made three other acquisitions

Medacta International acquires Vivamed

Medacta International has announced its acquisition of the Austrian distributor Vivamed. The acquisition went into effect on Feb. 1. Medacta, a privately held and family-owned global designer of joint replacement and spinal surgery products, hopes to strengthen its presence in Austria and facilitate future development and investments in the market with this acquisition. It also

Inside the largest medical acquisition in history

Heather Thompson/Senior Editor Trust between Medtronic and Covidien officials helped them overcome the political blowback from the two companies’ $50 billion merger of equals, which moved Medtronic’s official headquarters from Minnesota to Ireland.  That was a major takeaway when Brett Wall, former president of Covidien and current president of the neurovascular business at Medtronic, interviewed

Vention acquires nitinol wire component maker Lithotech Medical

Vention Medical said today that it acquired Israeli nitinol wire component maker Lithotech Medical. The acquisition grows Vention’s portfolio of advanced components and tech for the development and manufacturing of medical devices. “Partnering with this talented group of nitinol experts expands our portfolio of advanced components and technologies as well as our applications expertise,” Tom